Bron:

| 23697 x gelezen

STANFORD, Calif.– A preliminary study suggests there may be hope in the offing for some sufferers of chronic fatigue syndrome with a new therapy being tested by researchers at the Stanford University School of Medicine.

José Montoya, MD, associate professor of medicine (infectious diseases), and postdoctoral scholar Andreas Kogelnik, MD, PhD, have used the drug valganciclovir an antiviral often used in treating diseases caused by human herpes viruses to treat a small number of CFS patients.

Gerelateerd artikel (16-5-6): “Is this (a herpes drugs) the cure for ME?”

Lees het volledige artikel

Geef een reactie

Zijbalk

Volg ons
ma
di
wo
do
vr
za
zo
m
d
w
d
v
z
z
30
31
1
2
3
4
5
6
7
8
9
11
12
13
14
15
16
17
18
19
20
21
22
23
25
26
27
28
29
30
31
1
2
10 jan
10/01/2025    
20:00 - 21:00
NIH leaders will provide updates and answer questions about RECOVER’s latest efforts to identify safe and effective treatments for Long COVID. The National Institute of [...]
24 jan
24/01/2025    
19:00 - 20:30
Research Roundtable: Cell danger response (CDR) inhibition of salugenesis—molecular and mechanical mechanisms and possible treatments in ME/CFS Datum en tijd 24 jan 2025 07:00 p.m. in Brussel [...]
Events on 10/01/2025
Recente Links